ArticleFrontiers in digital health2025
Heart disease prediction with a feature-sensitized interpretable framework for the Internet of Medical Things sensors.
Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Validation of Artificial Intelligence Prediction of Epicardial Coronary Artery Spasm in Patients Without Obstructive Coronary Artery Disease.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cardiovascular health is increasingly at risk due to modern lifestyle factors such as obesity, smoking, stress, hypertension, and sedentary behavior. Post-pandemic health practices and medication side effects have further contributed to rising cases of early heart failure, particularly among individuals aged 25-40 years. This highlights the need for an automated and interpretable framework to predict heart disease at an early stage. Methods: In this study, body vitals acquired from a secondary dataset. Machine learning models including Support Vector Machine, Random Forest, Decision Tree, and Logistic Regression were employed for classification. Model performance was evaluated using accuracy, F1-score, and k-fold cross-validation. Results: Among the tested models, the Random Forest classifier demonstrated superior performance with an accuracy and F1-score of 0.955. The interpretability is enhanced with model predictions were explained using Local Interpretable Model-Agnostic Explanations (LIME) for local surrogates and SHAP values for global surrogates. SHAP decision plots provided clear insights into classification behaviour and feature contributions. Discussion/Conclusion: The proposed interpretable machine learning framework successfully predicts heart disease with high accuracy while maintaining transparency in decision-making. With the integration of sensor data with cloud-based analysis and explainable AI techniques, this study contributes to reducing the incidence of early heart failures and supports more reliable decision-making in healthcare applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.